Heart & Vascular Center

Heart & Vascular Center

Phone Numbers

Lexington Medical Heart and Vascular Center

Cardiology
(803) 744-4900
Cardiothoracic Surgery
(803) 936-3275
Vascular Surgery
(803) 936-7095

Cardiac Rehabilitation

Main Campus
(803) 791-2621
LMC Lexington
(803) 358-6180
LMC Irmo
(803) 732-5388

Research Trials

Ongoing Clinical Trials

  • Access to new treatments before they become available to everyone
  • Driving innovation in research
(803) 935-8300

"These were the best professionals I’ve ever seen. They were amazing."

— Lewis, Heart & Vascular Center Patient

Research Trials

We offer qualifying patients access to the latest clinical trials.

DEFIANCE

Description
Clot Triever Thrombectomy System vs. Anticoagulation alone for treatment of deep vein thrombosis.

The ClotTriever Thrombectomy System is an FDA cleared device designed to treat blood clots in the leg. The ClotTriever works by removing blood clots from vessels in your leg by trapping the clot.  The trapped clot is pulled into a metal mesh bag and then out of your body using a catheter. A catheter is a thin, flexible tube that is used to help remove blood clots.  

Open to enrollment. 

Posted By: Dr. Gerald Fortuna Jr.

Posted Date: 10/30/2023

Location: Heart and Vascular Center

PEERLESS Study

Description
The primary study objective is to compare the clinical outcomes of patients treated with the Flow Triever System versus Catheter-Directed Thrombolysis (CDT) for use in the treatment of acute intermediate-high-risk pulmonary embolism (PE).

Open to enrollment

Posted By: Dr. Robert Leonardi

Posted Date: 4/18/2022

Location: Heart and Vascular Center

ACURATE IDE

Description
ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve through Implantation of ACURATE in Subjects indicated for TAVR.

The purpose of this study is to evaluate the safety and effectiveness of the ACURATE Transfemoral Aortic Valve System for transcathereter aortic valve replacement (TAVR) in patients with severe native aortic stenosis who are indicated for TAVR.

Open to enrollment

Posted By: Dr. Robert Leonardi

Posted Date: 10/13/2023

Location: Heart and Vascular Center

PFO-PAS

Description
Single arm, multi-center study to confirm the safety and effectiveness of the AMPLATZER™ PFO Occluder in the Post-Approval Setting.

The purpose of this study is to collect additional information on the safety and effectiveness of the commercially approved Amplatzer PFO Occluder and Amplatzer Talisman PFO Occluder, devices used for patent foramen ovale (PFO) closure. 

Open to enrollment 

Posted By: Dr. Leonardi

Posted Date: 10/13/2017

Location: Heart and Vascular Center